Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPI1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | RBMXL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RFX3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MARK1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | TRMT1L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RPA3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF620 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | DTYMK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PSMA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |